On 14 May 2018
Hester Biosciences will hold a meeting of the Board of Directors of the Company on 14 May 2018, to consider the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2018 and to consider declaration of the final dividend, if any, on the equity shares of the Company, for the financial year 2017-18.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
